Hypogonadism Withdrawn Phase 0 Trials for Testosterone (DB00624)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Withdrawn0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01940718Androgen Regulation of Priapism in Sickle Cell DiseaseTreatment